Now that Research In Motion Ltd(NASDAQ:BBRY) has pinned all its hopes on the BlackBerry 10 to help the company make a comeback, one of BlackBerry’s biggest...
Zynga (NASDAQ:ZNGA) is up 2.5% after Benchmark reiterated its Buy rating in a look-ahead at Q2 earnings. The firm’s expecting a beat and solid guidance for...
Now that the market seems to be coming back into his elements, it could be time for investors to start looking into penny stocks more closely....
Over the course of the past year or so, pot stocks had generally struggled, but during the past month, those stocks have recovered nicely. The stock...
Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money...
Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money...
Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money...
BioPharmX (BPMX) has completed enrollment of 207 subjects in a Phase 2b clinical trial evaluating topical minocycline gel BPX-04 in patients with moderate-to-severe papulopustular rosacea, a...
Thinly traded micro cap Verrica Pharmaceuticals (VRCA +7.2%) is up on below average volume on the heels of successful results from two Phase 3 clinical trials,...
Shares of Nightstar Therapeutics (NASDAQ: NITE), a clinical-stage gene therapy company, jumped by a noteworthy 67.48% in pre-market trading today. The spark? Nightstar’s shares are bolting...
Kandi Technologies (NASDAQ:KNDI) says its joint venture with Geely signed a strategic cooperative agreement for operating government-accredited vehicles with China Resources Vehicle and Ship Natural Gas...